FDA Inspection 1180209 — Abba Pharma, Inc

Abba Pharma, Inc — FEI 3007100427

The FDA completed an inspection of Abba Pharma, Inc on September 23, 2022 in Tampa, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 23, 2022
Fiscal Year
2022
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Tampa, FL (United States)

Citations

IDCFRDescription
1556721 CFR 111.260(l)(4)Batch record - approved, released, rejected
1579121 CFR 111.403Written procedures -packaging operations